-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$45.22583.08% Upside
Recent Analyst Forecasts and Stock Ratings
Sage Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Sage Therapeutics, Inc.?
Sage Therapeutics, Inc. has been rated by research analysts at Truist Financial, Canaccord Genuity, Robert W. Baird, Scotiabank, Oppenheimer, RBC Capital in the past 90 days.